SCHEMBL1390265

SCHEMBL1390265

Cc1cc(C(=O)C=Cc2ccc(Br)cc2)ccn1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ P4HB P07237 1/20 0.56
▸ ESR1 P03372 1/20 0.54
▸ ESR2 Q92731 1/20 0.54
▸ MAPT P10636 7/20 0.52
▸ MAOB P27338 5/20 0.52
▸ MAOA P21397 3/20 0.52
▸ LMNA P02545 4/20 0.52
▸ ATM Q13315 2/20 0.52
▸ NTSR1 P30989 1/20 0.52
▸ CYP1B1 Q16678 1/20 0.51
▸ MEN1 O00255 2/20 0.49
▸ ALDH1A1 P00352 2/20 0.49
▸ POLB P06746 2/20 0.49
▸ KMT2A Q03164 2/20 0.49
▸ TLR9 Q9NR96 2/20 0.49
▸ TDP1 Q9NUW8 2/20 0.49
▸ L3MBTL1 Q9Y468 2/20 0.49
▸ USP2 O75604 1/20 0.49
▸ MAPK1 P28482 1/20 0.49
▸ RECQL P46063 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL362120 0.86 CYP1B1 (0.55) P4HBESR1ESR2MAPTMAOB
SCHEMBL363826 0.83 P4HB (0.56) P4HBESR1ESR2MAPTMAOB
SCHEMBL1390019 0.79 ESR1 (0.68) P4HBESR1ESR2MAPTMAOB
SCHEMBL28554002 0.77 CYP1A1 (0.41) MAPTLMNACYP1B1MEN1ALDH1A1
SCHEMBL30109641 0.77 JUN (0.52) CYP1B1MEN1KMT2A
SCHEMBL17053215 0.77 CYP1A1 (0.58) MAPTCYP1B1MEN1ALDH1A1KMT2A
SCHEMBL1659833 0.76 ESR1 (0.86) P4HBESR1ESR2MAPTMAOB
SCHEMBL1659832 0.76 ESR1 (0.86) P4HBESR1ESR2MAPTMAOB
SCHEMBL13558899 0.75 ESR1 (0.63) P4HBESR1ESR2MAPTMAOB
SCHEMBL22198763 0.75 MAPT (0.83) ESR1ESR2MAPTMAOBMAOA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 — — EP disclosed
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 — — US disclosed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES GPBAR1, GPR119, ADRB1 P4HB 884/4885ESR1 1231/4885ESR2 614/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback